|
REPORT COPYRIGHT VIOLATION IN REPLY
|
|
Message Subject
|
COVID-19 News, Info, Discussion /// Tracking the Spread of the Virus and its Effects /// October Lockdown for UK (pg. 774)
|
|
Poster Handle
|
CoronaCoaster |
|
Post Content
|
A vaccine which focuses on more than just the spike protein?
As the battle with Covid-19 rages around the world, a small French biotech has a possible solution for the long-term war against the virus and the rapidly spreading mutations.
The company, Valneva SE, has a vaccine that could be more variant-proof, giving it an edge over other shots
With all the other Covid-19 vaccines in the region focused on the virus’s spike protein, the shot could protect against variants that might compromise others
Kate Bingham, former head of the U.K.’s Vaccine Taskforce, says that if the shot is successful it will probably be used as a winter booster for older adults.
“Having that broader antigenic real estate from a whole virus vaccine really matters,” she said. “Viruses mutate. So by having a broader immune response, which you get with a whole vaccine, you can potentially provide that ongoing protection.” [ link to www.bloomberg.com (secure)]
|
|
|
Please verify you're human:
|
|
|
Reason for copyright violation:
|
